Literature DB >> 28197306

Potent Antifungal Synergy of Phthalazinone and Isoquinolones with Azoles Against Candida albicans.

Aaron D Mood1, Ilandari Dewage Udara Anulal Premachandra1, Stanley Hiew1, Fuqiang Wang2, Kevin A Scott1, Nathan J Oldenhuis1, Haoping Liu2, David L Van Vranken1.   

Abstract

Four phthalazinones (CIDs 22334057, 22333974, 22334032, 22334012) and one isoquinolone (CID 5224943) were previously shown to be potent enhancers of antifungal activity of fluconazole against Candida albicans. Several even more potent analogues of these compounds were identified, some with EC50 as low as 1 nM, against C. albicans. The compounds exhibited pharmacological synergy (FIC < 0.5) with fluconazole. The compounds were also shown to enhance the antifungal activity of isavuconazole, a recently FDA approved azole antifungal. Isoquinolone 15 and phthalazinone 24 were shown to be active against several resistant clinical isolates of C. albicans.

Entities:  

Keywords:  Candida albicans; antifungal agents; fluconazole; isoquinolone; phthalazinone; synergy

Year:  2017        PMID: 28197306      PMCID: PMC5304299          DOI: 10.1021/acsmedchemlett.6b00355

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  34 in total

Review 1.  Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.

Authors:  Jinhui Cui; Biao Ren; Yaojun Tong; Huanqin Dai; Lixin Zhang
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates.

Authors:  Willmen Youngsaye; Benjamin Vincent; Cathy L Hartland; Barbara J Morgan; Sara J Buhrlage; Stephen Johnston; Joshua A Bittker; Lawrence MacPherson; Sivaraman Dandapani; Michelle Palmer; Luke Whitesell; Susan Lindquist; Stuart L Schreiber; Benito Munoz
Journal:  Bioorg Med Chem Lett       Date:  2011-06-30       Impact factor: 2.823

3.  Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).

Authors:  Andrew G S Warrilow; Claire M Martel; Josie E Parker; Nadja Melo; David C Lamb; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

Review 4.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections.

Authors:  Corrado Girmenia; Mario Venditti; Pietro Martino
Journal:  Diagn Microbiol Infect Dis       Date:  2003-07       Impact factor: 2.803

6.  Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Sébastien Imbert; Priscillia Bresler; Alexandre Boissonnas; Lauraine Gauthier; Laëtitia Souchet; Madalina Uzunov; Véronique Leblond; Dominique Mazier; Stéphanie Nguyen; Arnaud Fekkar
Journal:  J Allergy Clin Immunol       Date:  2016-04-07       Impact factor: 10.793

7.  Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.

Authors:  Stephanie A Flowers; Katherine S Barker; Elizabeth L Berkow; Geoffrey Toner; Sean G Chadwick; Scott E Gygax; Joachim Morschhäuser; P David Rogers
Journal:  Eukaryot Cell       Date:  2012-08-24

8.  Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.

Authors:  Ilandari Dewage Udara Anulal Premachandra; Kevin A Scott; Chengtian Shen; Fuqiang Wang; Shelley Lane; Haoping Liu; David L Van Vranken
Journal:  ChemMedChem       Date:  2015-08-12       Impact factor: 3.466

9.  In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.

Authors:  D T A Te Dorsthorst; P E Verweij; J Meletiadis; M Bergervoet; N C Punt; J F G M Meis; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.

Authors:  Michaela Spitzer; Emma Griffiths; Kim M Blakely; Jan Wildenhain; Linda Ejim; Laura Rossi; Gianfranco De Pascale; Jasna Curak; Eric Brown; Mike Tyers; Gerard D Wright
Journal:  Mol Syst Biol       Date:  2011-06-21       Impact factor: 11.429

View more
  3 in total

1.  Identification of Some Promising Heterocycles Useful in Treatment of Allergic Rhinitis: Virtual Screening, Pharmacophore Mapping, Molecular Docking, and Molecular Dynamics.

Authors:  Amany Belal; Mohamed A Elanany; Reem I Alsantali; Munira M Alrooqi; Abdalla R Mohamed; Sherifa Hasabelnaby
Journal:  Russ J Bioorg Chem       Date:  2022-05-26       Impact factor: 1.254

Review 2.  Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox.

Authors:  Aidan Kane; Dee A Carter
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-14

3.  Isoquinolone-4-Carboxylic Acids by Ammonia-Ugi-4CR and Copper-Catalyzed Domino Reaction.

Authors:  Qian Wang; Kumchok C Mgimpatsang; Xin Li; Alexander Dömling
Journal:  J Org Chem       Date:  2021-06-29       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.